Clinical Trial: Evaluate the Safety and Preliminary Immunogenicity of a SARS-CoV-2 mRNA Vaccine in Adults
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: SARS-CoV-2
Study Type: INTERVENTIONAL
Official Title: Evaluate the Safety and Preliminary Immunogenicity of a SARS-CoV-2 mRNA Vaccine (RBMRNA) as a Booster Dose in Adults
Brief Summary:
This study is to evaluate the safety and preliminary immunogenicity of a SARS-CoV-2 mRNA Vaccine as a booster dose in adults who completed 2 doses of inactivated vaccination.
Read more